Select from our A to Z index of CMI (Consumer Medicines Information) leaflets for both prescription and over-the-counter medicines. Available as HTML, PDF and large font PDF.
glatiramer acetate
Consumer Medicine Information
This leaflet answers some common questions about Copaxone.
It does not contain all the available information. It does not take the place of talking to your doctor and pharmacist.
All medicines have risks and benefits. Your doctor has weighed the risks of you using this medicine against the benefits they expect it will have for you.
If you have any concerns about using this medicine, ask your doctor or pharmacist.
Keep this leaflet with the medicine. You may need to read it again.
Copaxone is used for the management of relapsing forms of Multiple Sclerosis (MS).
Copaxone may also be used in patients who, for the first time, have experienced symptoms and have MRI changes that indicate a high risk for development of MS. Your doctor will rule out any other reasons which could explain these symptoms before you are treated.
The cause of MS is not yet known. MS affects the brain and spinal cord. In MS, the body’s immune system reacts against its own myelin (the ‘insulation’ surrounding nerve fibres). In relapsing forms of MS, people can have ‘exacerbations’ from time to time (eg. blurred vision, weakness in the legs or arms, or loss of control of bowel or bladder function). These are followed by periods of recovery.
Although the exact mechanism of how Copaxone works in MS is unknown, it is thought that Copaxone works by changing the immune processes that are believed to be responsible for the disease.
Copaxone has been shown to be effective in reducing the number of relapses in patients with relapsing remitting MS. Although it is not a cure, patients treated with Copaxone generally find that they will experience fewer relapses.
Your doctor, however, may prescribe Copaxone for another purpose.
Ask your doctor or pharmacist if you have any questions about why it has been prescribed for you. This medicine is only available with a doctor’s prescription.
Do not use Copaxone if you are allergic to it or any of the ingredients listed at the end of this leaflet. Some symptoms of an allergic reaction include skin rash, itching, shortness of breath or swelling of the face, lips or tongue, which may cause difficulty in swallowing or breathing.
Do not give Copaxone to children. There is no experience with its use in children under 12 years of age.
Do not use it after the expiry date (EXP) printed on the pack. If you use it after the expiry date has passed, it may not work as well.
Do not use it if the packaging is damaged or shows signs of tampering
Tell your doctor or pharmacist if you have allergies to:
Tell your doctor if you are pregnant or intend to become pregnant. Like most medicines of this kind, Copaxone is not recommended to be used during pregnancy. Your doctor will discuss the risks and benefits of using it if you are pregnant.
Tell your doctor if you are breast-feeding or plan to breast-feed. It is not known whether Copaxone passes into breast milk. Your doctor will discuss the risks and benefits of using it if you are breast-feeding or planning to breast-feed.
Tell your doctor if you have or have ever had any medical conditions, especially the following:
Tell your doctor if you plan to have surgery.
If you have not told your doctor about any of the above, tell them before you use Copaxone.
Tell your doctor or pharmacist if you are taking any other medicines, including any that you buy without a prescription from your pharmacy, supermarket or health food store. Some medicines may interfere with the absorption of Copaxone.
These medicines may be affected by Copaxone, or may affect how well it works. You may need to use different amounts of your medicine, or take different medicines. Your doctor or pharmacist will advise you.
Your doctor or pharmacist has more information on medicines to be careful with or avoid while using Copaxone.
Follow all directions given to you by your doctor, MS education nurse or pharmacist. They may differ from the information contained in this leaflet.
The recommended dose of this medicine is one Copaxone 20mg pre-filled syringe (1mL) injected once a day.
Do not change the dose or dosing schedule or stop using Copaxone without talking to your doctor.
Copaxone is given by an injection into the fatty layer under the skin (subcutaneous injection).
Many people with MS learn to give themselves the injection or have it given by a carer.
Self-injection needs to be taught and practised. It is important that a qualified healthcare professional supervises your first injection.
Your doctor may teach you to self-inject or arrange for an MS education nurse to do so.
You may have a friend attend the injection training session as your assistant. Especially when you first start giving yourself injections, your assistant should be with you.
Talk to your doctor or the MS Society or telephone 1800 502 802 in Australia or 0800 283 684, Option 4 in New Zealand for more information. Patient support kits that include self-injection are available by telephoning 1800 502 802 in Australia or 0800 283 684, Option 4 in New Zealand.
After being taught to self-inject, you can refer to this leaflet for step-by-step instructions about how to prepare and inject Copaxone. The following instructions explain how to inject Copaxone yourself.
Do not attempt self-injection until you are confident that you understand how to inject yourself.
Please read these instructions carefully.
Copaxone pre-filled injection is pre-mixed and ready for you to use.
Make sure that the blister with the syringe inside is taken out of the refrigerator for 20 minutes before you use it. It is important that the solution is at room temperature when you inject it. If you need to delay your injection, return the blister, to its package in the refrigerator.
Always inspect Copaxone solution in the pre-filled syringe before you use it. Do not inject the solution if it is cloudy or has particles in it.
Gather the following items on a towel in a well-lit area:
Wash and dry your hands. Do not touch your hair or skin afterwards. This will help prevent infection.
There are seven injection areas on your body. Within each injection area there are multiple injection sites (Figure 1).
Rotate the injection sites within an area.
You should not use any site more than once each week. Marking a calendar will help you keep track of the sites you have used each day.

When you inject in the upper back portions of your arms, it is not possible to pinch 5 cm of skin with one hand and inject yourself with the other hand. Ask your doctor / nurse for instruction on how to use these areas.


Some patients may experience a side-effect known as the Immediate Post Injection Reaction (see the information under the heading ‘Side effects’ below).
Do not reuse the pre-filled syringe. Each pre-filled syringe should be used only for one injection.
Ask your doctor or nurse about obtaining a “sharps container”.
After use, place all used syringes and needles in a hard-walled plastic container, such as a liquid laundry detergent container. It is very important that you keep the cover of the container tightly shut and that you store it out of the reach of children. When the container is full, check with your doctor or nurse about proper disposal.
Give yourself the injection at the same time each day. Choose a time when you feel strongest.
Do not stop using Copaxone without checking with your doctor first. The positive effects of Copaxone are not seen immediately. They occur with long-term treatment.
If it is almost time for your next dose, skip the dose you missed and have your next injection when you are meant to.
Do not use a double dose to make up for the dose that you missed. This may increase the chance of you getting an unwanted side-effect.
If there is still a long time to go before your next dose, use it as soon as you remember, and then go back to using it as you would normally.
If you are not sure what to do, ask your doctor or pharmacist.
If you have trouble remembering when to use your medicine, ask your pharmacist or MS education nurse for some hints. It is important not to miss injections as this can affect the success of your treatment.
Immediately telephone your doctor or Poisons Information Centre (telephone Australia 13 11 26 or 0800 POISON or 0800 764766 in New Zealand), or go to Accident and Emergency at your nearest hospital, if you think that you or anyone else may have used too much Copaxone.
Do this even if there are no signs of discomfort or poisoning. You may need urgent medical attention.
Tell all the doctors, dentists and pharmacists who are treating you that you are using Copaxone.
If you are about to be started on any new medicine, tell your doctor and pharmacist that you are using Copaxone.
If you plan to have surgery that needs a general anaesthetic, tell your doctor or dentist that you are using this medicine.
If you become pregnant while you are using this medicine, stop using it and tell your doctor immediately.
Do not use more than the recommended dose unless your doctor tells you to.
Do not give this medicine to anyone else, even if they have the same condition as you.
All medicines have some unwanted side effects. Sometimes they are serious, but most of the time they are not. Your doctor has weighed the risks of using this medicine against the benefits they expect it will have for you.
Do not be alarmed by this list of possible side effects. You may not experience any of them.
Tell your doctor or pharmacist as soon as possible if you do not feel well while you are using Copaxone. It helps most people with MS, but it may have unwanted side effects in a few people.
Tell your doctor if you notice any of the following and they worry you:
Some patients may experience a side-effect known as the Immediate Post Injection Reaction. This reaction consists of the following symptoms:
These are mild side effects of this medicine and usually are short-lived.
Some patients may experience only one episode during the treatment period.
If any of the following happen, stop using this medicine and tell your doctor immediately, or go to Accident and Emergency at your nearest hospital:
These are very serious side effects. If you have them, you may have had a serious allergic reaction to Copaxone. You may need urgent medical attention or hospitalisation.
These side effects are very rare.
Tell your doctor or pharmacist if you notice anything else that is making you feel unwell. Other side effects not listed above may occur in some consumers.
Do not be alarmed by this list of possible side effects. You may not experience any of them.
Ask your doctor or pharmacist to answer any questions you may have.
If you have any queries about any aspect of your medicine, or any questions regarding the information in this leaflet, discuss them with your doctor or pharmacist.
Keep Copaxone in the pack until it is time to use it. Protect from direct light.
The medicine will not keep as well if taken out of the packaging.
Keep Copaxone pre-filled syringes in the refrigerator at 2°C to 8°C. In the event of refrigeration being unavailable, Copaxone may be stored below 25°C for up to one month.
Copaxone must not be frozen. Do not place in the freezer or freezing compartment of a refrigerator.
Do not store it or any other medicine in the bathroom, near a sink, or on a windowsill.
Do not leave it in the car. Heat and damp can destroy some medicines.
Keep it where children cannot reach it.
Please read the package insert carefully for full details, including self disposal of needles and syringes after use.
If your doctor tells you to stop using Copaxone, or the medicine has passed its expiry date, ask your pharmacist what to do with any that are left over.
Return any unused medicine to your pharmacist.
Copaxone is a clear colourless solution supplied in 1mL glass single use pre-filled syringes.
Copaxone is supplied in a box of 28 blister packed pre-filled syringes.
Ingredients
Active Ingredient:
Each Copaxone pre-filled syringe contains 20 mg glatiramer acetate.
Inactive Ingredients:
Each injection also contains:
Copaxone is supplied in Australia by:
sanofi-aventis australia pty ltd
12-24 Talavera Road
Macquarie Park NSW 2113
Copaxone is supplied in New Zealand by:
sanofi –aventis new zealand limited
Level 8, James and Wells Tower
56 Cawley Street
Ellerslie
Auckland
Australian Register Number: AUST R 98235
This leaflet was prepared in February 2010
®Registered Trademark
Published by MIMS/myDr May 2010